Long-term capital. Hands-on operators. Regional reach.
Chestnut invests in and builds consumer and healthcare businesses across Asia Pacific Region
About Us
A private investment arm across the entire healthcare and consumer value chain.
We acquire high-potential businesses and build them organically through commercial and operational discipline. Our portfolio spans the entire value chain, from pharmaceutical and beauty manufacturing to retail pharmacies, snacks, foods and national distribution.
$
0
M
Annual Revenue (2026E)
0
+
Companies in Portfolio
0
+
Export Countries
0
+
Total Employees
World-class Portfolio
Six sectors, one ecosystem
Long-term alignment and global expertise
From pharmaceuticals to snacks, our portfolio gives the Group strong leverage in co-innovation and distribution across the region.
Building on Ethics. Driven by Integrity
Growth across Chestnut
From $16M to $484M in six years
77% CAGR · 2019–2025F
2019
$16M
2020
$17M
2021
$40M
2022
$89M
2023
$170M
2024
$322M
2025F
$484M
Our Approach
How we build value after every acquisition
01
Product Innovation
02
Human Capital
03
Operational Excellence
04
Digitalization
Partner with us
Healthcare and Consumer, End to End
Healthcare
Pharma ManufacturingCDMOBranded HealthcareIP & PatentsMedical DevicesBeauty
Consumer
SnacksBiscuitsCocoaFrozen & Ready MealsProteinIngredients